The committee once again considered the pricing of KEYTRUDA for lung cancer at the meeting over an issue that emerged in mid-2018 - and the company is still giving no indication it will accept a reduction. …
Latest Video
New Stories
-
Recognition for Department of Health official
January 28, 2020 - - Latest News -
More confirmed speakers for BioPharmaDispatch 2020
January 28, 2020 - - Latest News -
Research Australia calls on government to scrap R&D Tax cut
January 28, 2020 - - Latest News -
Call for payers to encourage antibiotic R&D
January 28, 2020 - - Latest News -
Government confirms more cases of coronavirus
January 28, 2020 - - Latest News -
New report highlights growing gene and cell therapy industry
January 24, 2020 - - Latest News -
Australian access behind comparable countries?
January 24, 2020 - - Latest News